BR112012014161A2 - composição farmacêutica à base de teobromina e um descongestionante e seu uso no tratamento da tosse - Google Patents

composição farmacêutica à base de teobromina e um descongestionante e seu uso no tratamento da tosse

Info

Publication number
BR112012014161A2
BR112012014161A2 BR112012014161A BR112012014161A BR112012014161A2 BR 112012014161 A2 BR112012014161 A2 BR 112012014161A2 BR 112012014161 A BR112012014161 A BR 112012014161A BR 112012014161 A BR112012014161 A BR 112012014161A BR 112012014161 A2 BR112012014161 A2 BR 112012014161A2
Authority
BR
Brazil
Prior art keywords
decongestant
theobromine
cough
treatment
pharmaceutical composition
Prior art date
Application number
BR112012014161A
Other languages
English (en)
Portuguese (pt)
Inventor
John Brew
Robin Mark Bannister
Original Assignee
Biocopea Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocopea Ltd filed Critical Biocopea Ltd
Publication of BR112012014161A2 publication Critical patent/BR112012014161A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR112012014161A 2009-12-14 2010-12-14 composição farmacêutica à base de teobromina e um descongestionante e seu uso no tratamento da tosse BR112012014161A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0921805.8A GB0921805D0 (en) 2009-12-14 2009-12-14 Drug composition and its use in therapy
PCT/GB2010/052085 WO2011073646A1 (en) 2009-12-14 2010-12-14 Combination of theobromine with a decongestant and its use for the treatment of cough

Publications (1)

Publication Number Publication Date
BR112012014161A2 true BR112012014161A2 (pt) 2016-05-17

Family

ID=41667045

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012014161A BR112012014161A2 (pt) 2009-12-14 2010-12-14 composição farmacêutica à base de teobromina e um descongestionante e seu uso no tratamento da tosse

Country Status (19)

Country Link
EP (1) EP2512464A1 (enExample)
JP (2) JP2013513651A (enExample)
CN (2) CN102740843A (enExample)
AU (1) AU2010332494B2 (enExample)
BR (1) BR112012014161A2 (enExample)
CA (1) CA2784214C (enExample)
CO (1) CO6541630A2 (enExample)
EC (1) ECSP12012132A (enExample)
GB (1) GB0921805D0 (enExample)
IL (1) IL220383A (enExample)
MX (1) MX343222B (enExample)
NZ (1) NZ600243A (enExample)
PE (1) PE20121537A1 (enExample)
PH (1) PH12012501203A1 (enExample)
RU (1) RU2564904C2 (enExample)
SG (2) SG10201408377QA (enExample)
UA (1) UA105944C2 (enExample)
WO (1) WO2011073646A1 (enExample)
ZA (1) ZA201204293B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB201111485D0 (en) * 2011-07-05 2011-08-17 Biocopea Ltd Drug composition and its use in therapy
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB0910375D0 (en) 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2170488A1 (en) * 1993-09-07 1995-03-16 Sekhar Mitra Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
HUP9700654A2 (hu) 1997-03-26 1999-09-28 Dezső Korbonits Teobromin tartalmú köhögéscsillapító készítmények
US6417206B1 (en) * 2001-01-26 2002-07-09 Medpointe Healthcare Inc. Antitussive/antihist aminic/decongestant compositions
JP2002308761A (ja) * 2001-04-09 2002-10-23 Taisho Pharmaceut Co Ltd 風邪用咳止め薬
JP2003128549A (ja) * 2001-08-15 2003-05-08 Rohto Pharmaceut Co Ltd 粘膜適用組成物
JP4377564B2 (ja) * 2002-05-02 2009-12-02 ロート製薬株式会社 内服用組成物
RU2311919C2 (ru) * 2002-12-30 2007-12-10 Каунсел Оф Сайнтифик Энд Индастриал Рисерч Разработка противокашлевой и смягчающей горло травяной композиции
US20040202677A1 (en) * 2003-04-10 2004-10-14 Hopkins Kevin J. Method of enhanced regional body fat reduction
US20060153926A1 (en) * 2005-01-10 2006-07-13 Bascom Charles C Compositions, products and methods for controlling weight in a mammal
US20080003280A1 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs
CN100518775C (zh) * 2007-03-16 2009-07-29 邓丽菊 一种治疗咳喘的药物组合物及其制剂

Also Published As

Publication number Publication date
SG10201408377QA (en) 2015-02-27
UA105944C2 (uk) 2014-07-10
PE20121537A1 (es) 2012-12-21
IL220383A0 (en) 2012-08-30
ZA201204293B (en) 2013-02-27
SG181686A1 (en) 2012-07-30
ECSP12012132A (es) 2012-09-28
JP2013513651A (ja) 2013-04-22
PH12012501203A1 (en) 2012-11-05
RU2564904C2 (ru) 2015-10-10
MX343222B (es) 2016-10-28
RU2012129839A (ru) 2014-01-27
CA2784214C (en) 2018-01-09
CN102740843A (zh) 2012-10-17
IL220383A (en) 2017-01-31
EP2512464A1 (en) 2012-10-24
AU2010332494B2 (en) 2015-01-15
WO2011073646A1 (en) 2011-06-23
MX2012006625A (es) 2012-10-05
CA2784214A1 (en) 2011-06-23
CO6541630A2 (es) 2012-10-16
GB0921805D0 (en) 2010-01-27
NZ600243A (en) 2013-07-26
CN105816462A (zh) 2016-08-03
AU2010332494A1 (en) 2012-06-14
JP2016040279A (ja) 2016-03-24

Similar Documents

Publication Publication Date Title
IL274602A (en) Pharmaceutical tablets containing eltrombopag olamine, methods for their preparation and use thereof in the preparation of medicaments for treating thrombocytopenia
BR112012013148A2 (pt) formulação farmacêutica e uso
ATE542815T1 (de) Kokristalle und pharmazeutische zusammensetzungen damit
BRPI0807544A2 (pt) Sólido farmacêutico e dose de vacina
EP2413693A4 (en) SUBSTITUTED AZOANTHRACENE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE
HUE053357T2 (hu) Gyógyszerészeti készítmény és annak beadásai
HRP20170929T1 (hr) Farmaceutski pripravci i odgovarajući postupci za isporuku
CR10769A (es) Improvements in and relating to drive mechanisms suitable for use in drug delicery devices
NO20085420L (no) Farmasøytisk formulering med fenylefrin og preparater for absorpsjon i tykktarmen
BRPI1008045A2 (pt) derivados de aminotetralina, composições farmacêuticas contendo-os, e seu uso em terapia
BRPI1011876A2 (pt) "composição farmacêutica estável e métodos de uso da mesma"
BRPI1010621A2 (pt) derivado de imidazoquinolinonas, sua composição farmacêutica e seu uso
BRPI0923283A2 (pt) conjugados terapêuticos de peptídeo e usos dos mesmos
CL2007002967A1 (es) Forma cristalina a del compuesto 4-[3-(4-ciclopropancarbonil-piperazin-1-carbonil)-4-fluoro-bencil]-2h-ftalazin-1-ona; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de un
EP2037917A4 (en) Pharmaceutical composition comprising amlodipine and losartan
EP2123296A4 (en) Adjuvant for transdermal or transmucosal administration and pharmaceutical preparation containing the same
BR112013014189A2 (pt) composição farmacêutica que compreende transcinamaldeíco e o uso da mesma no tratamento de infecções
ATE530546T1 (de) Kokristalle und pharmazeutische zusammensetzungen damit
BRPI1009392A2 (pt) "formulação farmacêutica, e, uso de uma quantidade farmaceuticamente eficaz de uma formulação farmacêutica."
DE602008003816D1 (de) Pharmazeutische feste zubereitung mit benzazepinen und herstellungsverfahren dafür
BRPI1006666A2 (pt) " composição farmacêutica e uso de uma composição farmacêutica"
BR112012014161A2 (pt) composição farmacêutica à base de teobromina e um descongestionante e seu uso no tratamento da tosse
DE602008005137D1 (de) Chinolonverbindung und pharmazeutische zusammensetzung
GB0921803D0 (en) Drug composition and its use in therapy
DK2029561T3 (da) Tricyclisk forbindelse og farmaceutisk anvendelse deraf

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2494 DE 23-10-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.